| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.057 | 0.7 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.7 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |